Skip to main content

Table 3 Preoperational and postoperational VX2 tumor volume (mm3, mean ± SD) of different groups: pDNA/lipiodol (A), L-nanoplex/lipiodol (E), U-nanoplex/lipiodol (B), Ca-nanoplex/lipiodol (C), Pll-nanoplex (D). All the data were calculated with one-way analysis of variance and Fisher-LSD multiple comparison tests

From: Synergism of wt-p53 and synthetic material in local nano-TAE gene therapy of hepatoma: comparison of four systems and the possible mechanism

Groups

preopertion

1 w postopertion

2 w postopertion

A

1257.8 ± 259.49

1937.7 ± 691.15

3873.2 ± 1632.08

E

1169.9 ± 264.69

1860.2 ± 520.80

3789.2 ± 991.56

B

1066.6 ± 220.95

1598.3 ± 323.04

2010.6 ± 546.49a,b

C

1164.9 ± 258.87

1900.6 ± 375.93

3820.6 ± 1059.55c

D

1125.4 ± 216.84

1168.6 ± 177.51a,b,c,d

1950.1 ± 417.13a,b,d

  1. a,b,c,drepresent significant difference from group A, E, B, C respectively (P < 0.05)
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us